0002012935-26-000002.txt : 20260226 0002012935-26-000002.hdr.sgml : 20260226 20260226164620 ACCESSION NUMBER: 0002012935-26-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20260226 DATE AS OF CHANGE: 20260226 EFFECTIVENESS DATE: 20260226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QuantBio Absolute Return Fund LP CENTRAL INDEX KEY: 0002012935 ORGANIZATION NAME: EIN: 922057601 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-506178 FILM NUMBER: 26689881 BUSINESS ADDRESS: STREET 1: C/O OBERLAND CAPITAL MANAGEMENT LLC STREET 2: 1700 BROADWAY, 41ST FLOOR CITY: NEW YORK STATE: NY BUSINESS PHONE: 212-257-5850 MAIL ADDRESS: STREET 1: C/O OBERLAND CAPITAL MANAGEMENT LLC STREET 2: 1700 BROADWAY, 41ST FLOOR CITY: NEW YORK STATE: NY FORMER COMPANY: FORMER CONFORMED NAME: QuantBio Absolute Return LP DATE OF NAME CHANGE: 20240222 D/A 1 primary_doc.xml X0708 D/A LIVE 0002012935 QuantBio Absolute Return Fund LP C/O OBERLAND CAPITAL MANAGEMENT LLC 1700 BROADWAY, 41ST FLOOR NEW YORK NY NEW YORK 10019 212-257-5850 DELAWARE QuantBio Absolute Return LP Limited Partnership true 2023 JEAN-PIERRE NAEGELI C/O OBERLAND CAPITAL MANAGEMENT LLC 1700 BROADWAY, 41ST FLOOR NEW YORK NY NEW YORK 10019 Executive Officer ANDREW RUBINSTEIN C/O OBERLAND CAPITAL MANAGEMENT LLC 1700 BROADWAY, 41ST FLOOR NEW YORK NY NEW YORK 10019 Executive Officer Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0002012935-25-000001 2024-04-01 true true false 0 GALLATIN CAPITAL LLC 124738 None None 444 MADISON AVENUE 29TH FLOOR NEW YORK NY NEW YORK 10022 All States false Indefinite 36296333 Indefinite false 30 0 0 0 false QuantBio Absolute Return Fund LP DAVID DUBINSKY DAVID DUBINSKY AUTHORIZED SIGNATORY OF THE GENERAL PARTNER 2026-02-26